Faculty News
Professor Aswath Damodaran's research on pharmaceutical companies' profit margins is cited
—
![The Economist logo The Economist logo](/sites/default/files/styles/480w/public/assets/images/uat_025662.jpg?itok=nJDMr-JW)
Excerpt from The Economist -- "According to a recent study by Aswath Damodaran of New York University’s Stern School of Business, on this basis drug firms’ margins are 24%, higher than most other sectors (see chart)."
Read more
Read more